A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT

被引：0
|
作者：
Armin D Goralczyk
Andreas Schnitzbauer
Tung Y Tsui
Giuliano Ramadori
Thomas Lorf
Aiman Obed
机构：
[1] University Medical Center Göttingen,Department of General and Visceral Surgery
[2] Universitätsklinikum Regensburg,Klinik und Poliklinik für Chirurgie
[3] Universitätsklinikum Hamburg-Eppendorf,Department of Hepatobiliary and Transplant Surgery
[4] University Medical Center Göttingen,Department of Gastroenterology and Endocrinology
来源：
BMC Surgery | / 10卷
关键词：
Everolimus; Acute Rejection; Orthotopic Liver Transplantation; Immunosuppressive Regimen; Daclizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT
    Goralczyk, Armin D.
    Schnitzbauer, Andreas
    Tsui, Tung Y.
    Ramadori, Giuliano
    Lorf, Thomas
    Obed, Aiman
    [J]. BMC SURGERY, 2010, 10
  • [2] STUDY PROTOCOL: A THERAPEUTIC EXPLORATORY STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CALCINEURIN-INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION: CILT
    Goralczyk, Armin D.
    Schnitzbauer, Andreas
    Schlitt, Hans J.
    Lorf, Thomas
    Obed, Aiman
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 233 - 233
  • [3] A THERAPEUTIC EXPLORATORY STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CALCINEURIN-INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION (CILT): THE INTERIM ANALYSIS
    Goralczyk, A.
    Abu-Ajaj, W.
    Amazada, A.
    Ramadori, G.
    Lorf, T.
    Obed, A.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 42 - 42
  • [4] A Therapeutic Exploratory Study To Determine the Efficacy and Safety of Calcineurin-Inhibitor-Free De-Novo Immunosuppression after Liver Transplantation (CILT): The Interim Analysis
    Goralczyk, Armin D.
    Zwirner, Lennart
    Abu-Ajaj, Wijdan
    Ramadori, Giuliano
    Lorf, Thomas
    Obed, Aiman
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S210 - S210
  • [5] A THERAPEUTIC EXPLORATORY STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CALCINEURIN-INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION (CILT): THE INTERIM ANALYSIS
    Goralczyk, Armin D.
    Abu-Ajaj, Wijdan
    Ramadori, Giuliano
    Lorf, Thomas
    Obed, Aiman
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 327 - 327
  • [6] Efficacy and Safety of Calcineurin-Inhibitor-Free De-Novo Immunosuppression with Everolimus after Liver Transplantation
    Grazi, Gian Luca
    Cescon, Matteo
    Di Gioia, Paolo
    Ravaioli, Matteo
    Ponte, Elisa
    Sacchetti, Federico
    Vetrone, Gaetano
    Ercolani, Giorgio
    Morelli, Maria Cristina
    Pinna, Antonio D.
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S206 - S207
  • [7] EFFICACY AND SAFETY OF CALCINEURIN-INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION WITH EVEROLIMUS AFTER LIVER TRANSPLANTATION
    Grazi, Gian Luca
    Cescon, Matteo
    Di Gioia, Paolo
    Ravaioli, Matteo
    Ponte, Elisa
    Sacchetti, Federico
    Vetrone, Gaetano
    Ercolani, Giorgio
    Morelli, Maria Cristina
    Pinna, Antonio Daniele
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 57 - 58
  • [8] META-ANALYSIS OF THE SAFETY AND EFFICACY OF CALCINEURIN INHIBITORS FOR DE-NOVO IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION
    Goralczyk, Armin D.
    Lorf, Thomas
    Obed, Aiman
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 237 - 237
  • [9] De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results
    Meiser, Bruno
    Buchholz, Stefan
    Kaczmarek, Ingo
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2011, 16 (05) : 522 - 528
  • [10] First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation
    Meiser, B
    Reichart, B
    Adamidis, I
    Überfuhr, P
    Kaczmarek, I
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (04) : 827 - 831
12345